Significant Ownership of Two Seas Capital LP

Signature - Title
/s/ Sina Toussi - Sina Toussi/Managing Member of Two Seas Capital GP LLC, its general partner
Location
Rye, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Two Seas Capital LP.

Notify me when Two Seas Capital LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Two Seas Capital LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OMEX ODYSSEY MARINE EXPLORATION INC Common Stock, par value $0.0001 per share 10% $9,915,522 +$3,763,646 5,084,883 +61% Two Seas Capital LP 30 Sep 2025
GCI Gannett Co., Inc. Common Stock, par value $0.01 per share 9.6% $58,565,965 +$12,183,500 14,180,621 +26% Two Seas Capital LP 30 Sep 2025
CLMT Calumet, Inc. Common Stock, par value $0.01 per share 7.8% $123,233,818 +$41,152,454 6,752,538 +50% Two Seas Capital LP 30 Sep 2025
CORZ Core Scientific, Inc. Common Stock, par value $0.00001 per share 7.2% $327,199,120 -$36,836,800 22,472,467 -10% Two Seas Capital LP 15 Jan 2026
AVDL Avadel Pharmaceuticals plc Ordinary Shares, nominal value $0.01 per share 6.4% $91,156,646 +$17,899,736 6,155,074 +24% Two Seas Capital LP 30 Jun 2025
ABUS Arbutus Biopharma Corporation Common Shares, without par value 5.4% $38,326,973 10,443,317 Two Seas Capital LP 30 Jun 2025
MDRX Veradigm Inc. Common Stock, par value $0.01 per share 5.3% $27,369,642 5,823,328 Two Seas Capital LP 30 Sep 2025
INDV INDIVIOR PLC Ordinary Shares, $0.50 nominal value per share 5% $203,438,218 -$99,635,260 6,211,854 -33% Two Seas Capital LP 23 Dec 2025
ESPR Esperion Therapeutics, Inc. Common Stock, par value $0.001 per share 4.7% $25,836,769 -$543,915 9,749,724 -2.1% Two Seas Capital LP 30 Sep 2025
ADAP Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share 0% $0 -$17,612,947 0 -100% Two Seas Capital LP 30 Sep 2025

Schedules 13D/G Reported by Two Seas Capital LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.